Analysis
Eli Lilly's $2.875B Merida Bet: How GLP-1 Riches Fund the Next Wave of Biotech M&A
Eli Lilly ($LLY) announces up to $2.875B acquisition of Merida Biosciences, signaling aggressive use of GLP-1 …
Sarah Chen • Aug 31
Markets
Aon's $17B Acquisition of USI: Market Implications and Trader Strategies
Aon’s acquisition of USI for $17B could reshape the market landscape. Here's what traders need to know.
James McAllister • Aug 31
Economy
Escalating US-Iran Tensions: What It Means for Oil Prices and Energy Stocks
As US-Iran tensions rise, investors eye the potential impacts on oil prices and North American energy stocks.
Marcus Rivera • Aug 31
Analysis
Eli Lilly's Strategic Move: $2.875B Acquisition of Merida Biosciences
Eli Lilly is set to acquire Merida Biosciences for up to $2.875B, marking a significant move in the biotech se…
Sarah Chen • Aug 31
Analysis
GFL Environmental's Sales Process Advances: What This Means for Shareholders
GFL Environmental's shares are on the rise with the Secure Waste division's impending sale. Here’s what shareh…
Marcus Rivera • Aug 30
Earnings
AI Earnings Showcase Strength: Salesforce, CrowdStrike & Nvidia Set the Stage
Salesforce, CrowdStrike, and Nvidia exceeded earnings expectations, indicating robust growth in AI sectors.
Sarah Chen • Aug 30
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
More Stories